• Array

Health

The rationale

  • The increase in health expenditures has become a common concern for health policy makers in most countries in the last few decades. Ageing populations, the cost of health technology, and the transition of the burden of disease towards chronic conditions have been the main determinants of such an increase in expenditures. The concern has become a priority, especially in times of economic crisis, where health expenditures—usually public expenditures—are cut while the population is demanding an increase in the quality of healthcare provision.

How to address the challenges

  • Understanding how health systems work and perform.
  • Determining how efficient health service provision is and how to improve it.
  • Creating awareness of the importance of public health promotion and prevention in the national agendas.
  • Assessing the right balance between public financing and public and private provision of health services.
  • Launching pilot programs for health service innovation and health information.
  • Launching R&D and innovation programs adapted to the needs of health institutions and pharmaceutical companies.

The Challenges

  • Increasing health expenditures threaten the sustainability of many countries that need to control public expenditures.
  • Different countries have different health systems, but all are willing to provide universal care of high quality services at a low cost.
  • The high cost of health technology innovation forces countries to make tough decisions about whether public insurance should reimburse new pharmaceutical products or services.
  • The organization of health service provision needs to adapt to the real needs of the population.

Our products

  • Diagnosis of health technology innovation.
  • International benchmarking and best practices.
  • Advice on statistical work for health planning, organization and provision of health services.
  • Expert advice for health policies

Manuel García-GoñiDirector

Associate Professor of Applied Economics at Complutense University of Madrid. Manuel earned his Ph.D. in Economics and MA in Political Economy at Boston University, specialized in the fields of Health Economics and Industrial Organization. He has acted as Visiting Scholar at Columbia University, as Visiting Fellow at the Australian National University at Canberra, and as Visiting Professor at Universidade Nova de Lisboa, Universitatea de Vest din Timisoara, Universidade do Porto, and Universidad Carlos III de Madrid.

Since 2004 Manuel has been Academic Secretary and Director of the Spanish Encounter of the Drug Industry that takes place annually at Universidad Internacional Menéndez Pelayo in Santander, Spain; between 2006 and 2012, he was a member of the Boards of Directors at the Spanish Health Economics Association, and the Chair of the Scientific Committee for the Spanish Health Economics Conference in 2012.

Manuel has published in peer reviewed economic journals as Health Economics, Health Policy, Research Policy, European Journal of Health Economics, or Ageing & Society, among others. His research has been funded by institutions such as the European Commission, the Centers for Medicare & Medicaid Services (United States), the Institute for Fiscal Studies (Spain), or the Ramon Areces Foundation (Spain).

Complete Bio

SELECTED PUBLICATIONS & REPORTS

  • Baji P., García-Goñi M., Gulacsi L., Mentzakis E., and Paolucci F. (2015). Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries. European Journal of Health Economics. Forthcoming.
  • García-Goñi M., Nuño-Solinís R., Orueta J.F., and Paolucci F. (2015). Is utilisation of health services for HIV patients equal by socioeconomic status? Evidence from the Basque Country. International Journal of Equity in Health, 14:110.
  • Paolucci F., Sowa P.M., García-Goñi M., and Ergas H. (2015). Mandatory aged care insurance: a case for Australia. Ageing and Society 35(2): 231-245.
  • Rubalcaba, L., Gallouj, F., Windrum, P., and Toivonen, M. (2014) Service innovation and social innovation: An analytical framework and its application to health services Advances in The Human Side of Service Engineering Edited By Louis Freund and Wojciech Cellary. Proceedings of the 5th AHFE Conference 19-23 July 2014: 623-636
  • Orueta J.F., García-Álvarez A., García-Goñi M., Paolucci F., and Nuño-Solinís R. (2014). Prevalence and costs of multimorbidity by deprivation levels in the Basque Country. A population based study using health administrative databases. PLoS ONE 9(2): e89787.
  • García-Goñi M., Hernández-Quevedo C., Nuño-Solinís R., and Paolucci F. (2012). Pathways towards chronic care-focused healthcare systems: evidence from Spain. Health Policy 108: 236–245.

  • Carreras M., García-Goñi M., et al. (2011). Estimates of costs related with population morbidity: changes in predictive power when overheads are allocated. European Journal of Health Economics 12:289–295.
  • García-Goñi M., Ibern P., and Inoriza J.M. (2009). Hybrid Risk Adjustment for Pharmaceutical Benefits. European Journal of Health Economics 10:299–308.
  • García-Goñi M., Ibern P. (2008). Predictability on drug expenditures: an application using morbidity data. Health Economics 17(1):119-126.
  • Windrum P., García-Goñi M. (2008). A neo-Schumpeterian model of health services innovation. Research Policy 37(4):649-672.
  • García-Goñi M., Maroto A., and Rubalcaba L. (2007). Innovation and worker motivation in public health. Health Policy 84(2-3):344-358.

BACK